SEC Filings

GlaxoSmithKline PLC
05 March 2004



                SEC FILINGS - REGISTRATION STATEMENT ON FORM F-3



GlaxoSmithKline plc (GSK) yesterday furnished to the US Securities and Exchange
Commission two Form 6-Ks. These filings comprise the results announcements for
the second quarter of 2003 and the year ended 31st December 2003, restated in
accordance with US Generally Accepted Accounting Principles, and have been made
in support of the company's Registration Statement on Form F-3.

Copies of the filings can be obtained from the Company Secretary's office or
from the SEC's website at www.sec.gov.

S M Bicknell
Company Secretary
5th March 2004


                      This information is provided by RNS
            The company news service from the London Stock Exchange